Cargando…
Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
Lessons learned from decades-long practice in the transplantation of hematopoietic stem and progenitor cells (HSPCs) to treat severe inherited disorders or cancer, have set the stage for the current ex vivo gene therapies using autologous gene-modified hematopoietic stem and progenitor cells that ha...
Autores principales: | Buffa, Valentina, Alvarez Vargas, José Roberto, Galy, Anne, Spinozzi, Simone, Rocca, Céline J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868335/ https://www.ncbi.nlm.nih.gov/pubmed/36698790 http://dx.doi.org/10.3389/fgeed.2022.997142 |
Ejemplares similares
-
Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
por: Murugesan, Ramya, et al.
Publicado: (2023) -
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
por: Ferrari, Samuele, et al.
Publicado: (2021) -
Prime editing in hematopoietic stem cells—From ex vivo to in vivo CRISPR-based treatment of blood disorders
por: Wolff, Jonas Holst, et al.
Publicado: (2023) -
Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseases
por: Cruz, Luis J., et al.
Publicado: (2022) -
Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem Cells
por: Benitez, Elizabeth K., et al.
Publicado: (2020)